A Daily Network publication
Explore the network
Wealth Advisor Daily
The advisor's edition — practice, portfolio, and the book.
Wednesday, October 7, 2026The Morning Brief →Sign in

Who holds DFTXDefinium Therapeutics

12 funds on our shelf carry Definium Therapeutics — heaviest hand: XPH at 3.09% of its book.

FundWeightFund assetsShares held
XPHState Street SPDR S&P Pharmaceuticals ETFINDEX3.09%$487M281,317
IHEiShares U.S. Pharmaceuticals ETFINDEX1.14%$1.6B478,266
PPHVanEck Pharmaceutical ETFINDEX0.49%$1B131,653
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.34%$112M9,597
IBBiShares Biotechnology ETFINDEX0.33%$10.6B969,956
VTWGVanguard Russell 2000 Growth ETFINDEX0.32%$1B142,070
IWOiShares Russell 2000 Growth ETFINDEX0.31%$14.4B1,173,677
VTWOVanguard Russell 2000 ETFINDEX0.16%$9.9B748,011
VFMOVanguard U.S. Momentum Factor ETFINDEX0.16%$646M84,158
IWMiShares Russell 2000 ETFINDEX0.16%$79.3B3,272,433
RSSLGlobal X Russell 2000 ETFINDEX0.15%$1.5B59,217
VHTVanguard Health Care Index FundINDEX0.06%$19B344,375

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

The latest from Wealth Advisor Daily, in your inbox every weekday. Free.